Alpha Crest Capital Management LLC Exelixis, Inc. Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $2.08 Million - $2.95 Million	132,670 Added 310.72%	175,367 $2.75 Million
Q2 2022 Aug 11, 2022	SELL	$17.44 - $23.16 $573,531 - $761,639	-32,886 Reduced 43.51%	42,697 $889,000
Q1 2022 May 12, 2022	SELL	$17.03 - $22.67 $1.1 Million - $1.46 Million	-64,469 Reduced 46.03%	75,583 $1.71 Million
Q4 2021 Feb 09, 2022	BUY	$15.84 - $21.88 $1.3 Million - $1.79 Million	82,012 Added 141.3%	140,052 $2.56 Million
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $296,008 - $383,902	-18,160 Reduced 23.83%	58,040 $1.23 Million
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $1.1 Million - $1.57 Million	61,323 Added 412.2%	76,200 $1.39 Million
Q1 2021 May 13, 2021	BUY	$20.53 - $25.22 $305,424 - $375,197	14,877 New	14,877 $336,000
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $226,840 - $305,908	-12,335 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $47,003 - $61,261	2,274 Added 22.6%	12,335 $302,000
Q2 2020 Aug 12, 2020	SELL	$16.46 - $27.42 $175,694 - $292,681	-10,674 Reduced 51.48%	10,061 $239,000
Q1 2020 May 13, 2020	BUY	$14.46 - $21.8 $299,828 - $452,023	20,735 New	20,735 $357,000
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $969,600 - $1.21 Million	-64,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$17.68 - $22.65 $915,824 - $1.17 Million	51,800 Added 424.59%	64,000 $1.13 Million
Q2 2019 Aug 12, 2019	SELL	$18.93 - $24.75 $654,978 - $856,350	-34,600 Reduced 73.93%	12,200 $261,000
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $572,320 - $722,992	29,200 Added 165.91%	46,800 $1.11 Million
Q4 2018 Feb 11, 2019	BUY	$13.65 - $21.8 $240,240 - $383,680	17,600 New	17,600 $346,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account